Carbon dioxide anesthesia euthanasia causes animal death through direct or indirect hypoxia. It can be used in various places and can cause animals to lose consciousness at different speeds. To achieve painless and painless death, one must lose consciousness before the movement (muscle activity) disappears. However, the disappearance of actions does not equate to the loss of consciousness and the absence of pain. Therefore, drugs that can only cause muscle paralysis but cannot cause animals to lose consciousness cannot be used as standalone euthanasia drugs. The carbon dioxide method may induce motor activity in animals after losing consciousness, but these motor activities are only reflex activities and cannot be perceived by animals. Therefore, it can be used independently as a method of euthanasia.

The traditional methods of animal death, such as decapitation and bloodletting, are relatively cruel and can easily have a negative impact on the psychological well-being of experimental personnel; The method of ether anesthesia leading to death is even less likely, as it is flammable, explosive, and highly carcinogenic, causing greater harm to experimental personnel. Carbon dioxide euthanasia has high safety and can effectively reduce the pain and suffering of experimental animals.

The system is compact in size, occupies a small space, and can effectively reduce the use of carbon dioxide. It is easy to learn, use, and operate.

The carbon dioxide anesthesia euthanasia method is more in line with animal welfare.

AutomaticAnimal euthanasia system

Model: CL-1000

The CL-1000 small animal euthanasia system adopts an automated control method of carbon dioxide hypoxia induced death, which controls and increases the concentration of carbon dioxide in the box. After reaching a certain concentration, the gas source is automatically cut off to maintain a certain induction time, and the animal is quickly induced to die without disturbance and minimal pain.

Compared with the conventional manual flow control euthanasia box, the CL-1000 small animal euthanasia system has significant advantages:

Convenient to use: high degree of automation, one click completion of operations;

Effort saving: The system can automatically inflate, maintain, and remove exhaust gases;

Adjustable parameters: flow rate, ventilation time, maintenance time, and exhaust gas cleaning time are adjustable and controllable;

Safer to use: Automatically removes a large amount of carbon dioxide and exhaust gas from the box, ensuring the safety of the laboratory, and can perform multiple batches of experimental operations continuously;

IntegratedSmall animal euthanasia system

model: CL-2000

Main features:

·The device is designed as an integrated unit and can be used separately on the experimental platform

·The system can preset a program to automatically introduce a set amount of carbon dioxide into the euthanasia box

·Multiple parameters can be set: flow rate, ventilation time, maintenance time, exhaust gas flushing time, UV sterilization time

·After setting the parameters, the entire process of animal anesthesia, euthanasia, and exhaust gas removal can be completed with one click operation, without the need for human supervision during the process

·CO2 gas inlet flow rate: 0-50L/min, digital display, regulation accuracy of 0.01L/min

·The equipment is equipped with a CO2 sensor, which can detect the concentration of CO2 in the box in real time and adjust and control the concentration of CO2 in the box

·Full touch screen operation, user-friendly interface design, multiple operating states can be displayed on the same screen on the display screen

Manual euthanasia box

Multiple models to choose from, and more suitable solutions can also be customized according to laboratory needs. Please call us for consultation：

Customized euthanasia box

No carbon dioxide exhaust gas leakage, suitable for SPF barrier laboratory

model: LC-800-S1

Partial references:

1. Li J, Zhang Z, Qiu J, Huang X. 8-Methoxypsoralen has Anti-inflammatory and Antioxidant Roles in Osteoarthritis Through SIRT1/NF-κB Pathway. Frontiers in Pharmacology. 2021-September-06 2021; twelve
2. Xu L, Wang S, Shen H, et al. Analgesic and toxic effects of venenum bufonis and its constituent compound cinobufagin: A comparative study. Neurotoxicology and Teratology. 2019; 73:49-53.
3. Tian J, Zhou D, Xiang L, et al. Calycosin represses AIM2 inflammasome-mediated inflammation and pyroptosis to attenuate monosodium urate-induced gouty arthritis through NF-κB and p62-Keap1 pathways. Drug Development Research. 2022/11/01 2022; 83(7):1654-1672.
4. Li Y, Yu H, Lv M, Li Q, Zou K, Lv S. Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis. BMC Pulmonary Medicine. 2022; 22(1):388.
5. Cui Q, Zhang D, Kong D, et al. Co-transplantation with adipose-derived cells to improve parathyroid transplantation in a mice model. Stem Cell Research & Therapy. 2020; 11(1):1-14.
6. Hu Q, Gao M, Zhang D, et al. De novo assembly and transcriptome characterization: Novel insights into the mechanisms of primary ovarian cancer in Microtus fortis. Molecular Medicine Reports. 2022; 25(2):1-9.
7. Hu C-B, Jiang H, Yang Y, et al. DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease. Neural Regeneration Research. 2023; 18(1):194.
8. Guo G, Sun L, Yang L, Xu H. IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis. Cell Cycle. 2019; 18(20):2598-2613.
9. Pan W, Xu X, Wang Y, Song X. Interleukin‑35 reduces inflammation in acute lung injury through inhibiting TLR4/NF‑κB signaling pathways. Experimental and Therapeutic Medicine. 2020; 19(3):1695-1700.
10. Zhao C, Jiang Q, Chen L, Chen W. LncRNA LINC01535 promotes colorectal cancer development and chemoresistance by sponging miR‑761. Experimental and Therapeutic Medicine. 2021; 22(1):1-10.
11. Guan X, Xu Y, Zheng J. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression. Oncol Rep. 2020/12/01 2020; 44(6):2465-2474.
12. Meng Q, Wang X, Guo D, et al. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches. 2022; 57(5):749-758.
13. Liang P, Liu J, Xiong J, et al. Neural stem cell-conditioned medium protects neurons and promotes propriospinal neurons relay neural circuit reconnection after spinal cord injury. Cell transplantation. 2014; 23(1_suppl):45-56.
14. Li Z, Bi H, Jiang H, et al. Neuroprotective effect of emodin against Alzheimer's disease via Nrf2 signaling in U251 cells and APP/PS1 mice. Molecular medicine reports. 2021; 23(2):1-1.
15. Ni B, Chen Z, Shu L, et al. Nrf2 Pathway Ameliorates Bladder Dysfunction in Cyclophosphamide-Induced Cystitis via Suppression of Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2021; two thousand and twenty-one
16. Jiao Y, Li F, Chen M, et al. Pre-treatment with morphine prevents lipopolysaccharide-induced acute respiratory distress syndrome in rats via activation of opioid receptors. Experimental Cell Research. 2022; 418(1):113224.
17. Liu Y, Duan Y, Du D, Chen F. Rescuing Kv10. 2 protein changes cognitive and emotional function in kainic acid-induced status epilepticus rats. Epilepsy & Behavior. 2020; 106:106894.
18. Ji L, Guo W. Single-cell RNA sequencing highlights the roles of C1QB and NKG7 in the pancreatic islet immune microenvironment in type 1 diabetes mellitus. Pharmacological Research. 2023/01/01/ 2023; 187:106588.
19. Wu M, Gong Y, Jiang L, et al. VEGF regulates the blood‑brain barrier through MMP‑9 in a rat model of traumatic brain injury. Experimental and Therapeutic Medicine. 2022; 24(6):1-10.
20. Hu A, Lu T, Chen D, et al. Vps4b heterozygous mice do not develop tooth defects that replicate human dentin dysplasia I. BMC genetics. 2019; 20:1-10.

：，

：

yuyanbio

： yuyanbio